Literature DB >> 19597698

IgG subclass serum levels in systemic lupus erythematosus patients.

Gui-gao Lin1, Jin-ming Li.   

Abstract

IgG subclass levels of sera from 105 patients with systemic lupus erythematosus (SLE) were determined by immunonephelometric assay. Patients were divided into two groups according to clinical activity of the disease: active disease and remission. Forty-five normal controls were also measured. We found a significant increase of IgG1 (p = 0.000), IgG2 (p = 0.000), and IgG3 (p = 0.000) in SLE sera, while IgG4 (p = 0.494) values did not differ significantly from those of controls. When patients were divided according to clinical activity, decrease of IgG3 concentration was observed in the patients in remission. In contrast, the concentrations of IgG1, IgG2, and IgG4 subclass were similar between the two groups (p > 0.05). Our data suggest that differential increase of IgG subclasses during the course of SLE may be of relevance to the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19597698     DOI: 10.1007/s10067-009-1224-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  14 in total

1.  An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study.

Authors:  C T Ravirajan; L Rowse; J R MacGowan; D A Isenberg
Journal:  Rheumatology (Oxford)       Date:  2001-12       Impact factor: 7.580

2.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Authors:  C Bombardier; D D Gladman; M B Urowitz; D Caron; C H Chang
Journal:  Arthritis Rheum       Date:  1992-06

3.  Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy.

Authors:  Aki Kuroki; Takanori Shibata; Hirokazu Honda; Daisuke Totsuka; Kenji Kobayashi; Tetsuzo Sugisaki
Journal:  Intern Med       Date:  2002-11       Impact factor: 1.271

4.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

5.  [The relation between IgG subclasses and clinical manifestations in patients with active systemic lupus erythematosus].

Authors:  M Tsujimura; Y Tokano; Y Takasaki; H Hashimoto
Journal:  Nihon Rinsho Meneki Gakkai Kaishi       Date:  1997-02

6.  Predominance of IgG1 and IgG3 subclasses of autoantibodies to neutrophil cytoplasmic antigens in patients with systemic lupus erythematosus.

Authors:  I Manolova; M Dancheva; K Halacheva
Journal:  Rheumatol Int       Date:  2002-04       Impact factor: 2.631

7.  An IgG subclass imbalance in connective tissue disease.

Authors:  R A Kay; K J Wood; R M Bernstein; P J Holt; R S Pumphrey
Journal:  Ann Rheum Dis       Date:  1988-07       Impact factor: 19.103

8.  Subclasses of IgG anticardiolipin antibodies in patients with systemic lupus erythematosus.

Authors:  U Tiikkainen; A Wangel; S L Appleton; D Arthur
Journal:  Scand J Immunol       Date:  1991-09       Impact factor: 3.487

9.  IgG subclasses in systemic lupus erythematosus and other autoimmune rheumatic diseases.

Authors:  F Blanco; J Kalsi; C T Ravirajan; P Speight; A R Bradwell; D A Isenberg
Journal:  Lupus       Date:  1992-12       Impact factor: 2.911

10.  Evaluation of human IgG subclass assays on Beckman array.

Authors:  M Pressac; F Allouche; R Circaud; P Aymard
Journal:  Ann Clin Biochem       Date:  1995-05       Impact factor: 2.057

View more
  11 in total

1.  Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus.

Authors:  David A Savitsky; Hideyuki Yanai; Tomohiko Tamura; Tadatsugu Taniguchi; Kenya Honda
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

2.  Hydroxychloroquine Therapy and Serum Immunoglobulin Levels in Women with IgG Subclass Deficiency and Systemic Lupus Erythematosus, Sjögren Syndrome, and Rheumatoid Arthritis: A Retrospective Study.

Authors:  James C Barton; J Clayborn Barton; Luigi F Bertoli
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2022-04-11       Impact factor: 4.291

3.  Pathologies Associated with Serum IgG4 Elevation.

Authors:  Mikael Ebbo; Aurélie Grados; Emmanuelle Bernit; Frederic Vély; José Boucraut; Jean-Robert Harlé; Laurent Daniel; Nicolas Schleinitz
Journal:  Int J Rheumatol       Date:  2012-08-26

4.  Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation.

Authors:  Hyemee Joo; Christine Coquery; Yaming Xue; Ingrid Gayet; Stacey R Dillon; Marilynn Punaro; Gerard Zurawski; Jacques Banchereau; Virginia Pascual; Sangkon Oh
Journal:  J Exp Med       Date:  2012-06-11       Impact factor: 14.307

5.  Serum IgG subclasses in autoimmune diseases.

Authors:  Haoze Zhang; Ping Li; Di Wu; Dong Xu; Yong Hou; Qian Wang; Mengtao Li; Yongzhe Li; Xiaofeng Zeng; Fengchun Zhang; Qun Shi
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

6.  Association between IgG4 Autoantibody and Complement Abnormalities in Systemic Lupus Erythematosus.

Authors:  Qingjun Pan; Linjie Guo; Jing Wu; Jun Cai; Huanjin Liao; Qiaofen Lan; Yanxia Peng; Yiming He; Hua-Feng Liu
Journal:  Mediators Inflamm       Date:  2016-08-11       Impact factor: 4.711

7.  Immunoglobulin G subtypes-1 and 2 differentiate immunoglobulin G4-associated sclerosing cholangitis from primary sclerosing cholangitis.

Authors:  Miroslav Vujasinovic; Pia Maier; Hartwig Maetzel; Roberto Valente; Raffaella Pozzi-Mucelli; Carlos F Moro; Stephan L Haas; Karouk Said; Caroline S Verbeke; Patrick Maisonneuve; J-Matthias Löhr
Journal:  United European Gastroenterol J       Date:  2020-04-29       Impact factor: 4.623

8.  Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients.

Authors:  Umberto Basile; Mariapaola Marino; Cecilia Napodano; Krizia Pocino; Paolo Emilio Alboini; Francesca Gulli; Amelia Evoli; Carlo Provenzano; Emanuela Bartoccioni
Journal:  J Immunol Res       Date:  2018-03-25       Impact factor: 4.818

9.  Lactobacillus acidophilus Supplementation Exerts a Synergistic Effect on Tacrolimus Efficacy by Modulating Th17/Treg Balance in Lupus-Prone Mice via the SIGNR3 Pathway.

Authors:  Da Som Kim; Youngjae Park; Jeong-Won Choi; Sung-Hwan Park; Mi-La Cho; Seung-Ki Kwok
Journal:  Front Immunol       Date:  2021-12-10       Impact factor: 7.561

10.  Factors associated with IgG levels in adults with IgG subclass deficiency.

Authors:  James C Barton; Jackson Clayborn Barton; Luigi F Bertoli; Ronald T Acton
Journal:  BMC Immunol       Date:  2021-08-09       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.